Dr. Paggiarino has previously held several executive positions in the area of ophthalmology for companies including Alcon, Pfizer Global R&D and Pharmacia Global.
Lpath is currently developing drugs for wet macular degeneration and renal cell carcinoma patients.
More Articles on Ophthalmology:
3 Statistics on Cataract Surgery Procedure Times in ASCs
New York Medical Society Names Dr. Sam Unterricht President
Study Finds Optomap Increases Retinal Lesion Detection
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
